NextCure, Inc.NXTCNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.35% | +0.37% | +1.87% | +14.79% | +50.21% |
| Weighted Average Shares Diluted Growth | +0.35% | +0.37% | +1.87% | +14.79% | +50.21% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | -100.00% | -100.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -36.85% | -41.70% | -53.51% | -56.15% | -37.94% |
| Book Value per Share Growth | -42.98% | -43.82% | -63.64% | -72.75% | -64.47% |
| Debt Growth | -9.93% | -25.82% | -24.23% | -18.13% | -13.38% |
| R&D Expense Growth | -24.73% | -30.72% | +94.00% | -30.03% | -27.63% |
| SG&A Expenses Growth | -10.35% | -14.62% | -5.16% | -24.59% | -16.97% |